Clinicians will soon be able to offer patients with schizophrenia who are initiating the long-acting...

The Food and Drug Administration (FDA) on Wednesday announced the approval of Lucemyra (lofexidine h...

The Food and Drug Administration (FDA) this week issued a safety announcement warning that the antic...

The Food and Drug Administration (FDA) on Monday approved Abilify MyCite—aripiprazole tablets with a...

The Food and Drug Administration last week announced that it has cleared the first mobile app to hel...

The Food and Drug Administration on Tuesday announced that a new warning of the serious adverse outc...